Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6) (Middle Region) Peptid
SSX6
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN984481
Kurzübersicht für Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6) (Middle Region) Peptid (ABIN984481)
Target
SSX6
(Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SSX6 antibody (Catalog #: ARP36225_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SSX6 (Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
-
Hintergrund
-
SSX6 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy.The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation.
Alias Symbols: dJ54B20.1, SSXP2, psiSSX2
Protein Size: 188 -
Molekulargewicht
- 22 kDa
-
Gen-ID
- 280657
-
NCBI Accession
- NM_173357, NP_775493
-
UniProt
- Q7RTT6
Target
-
Sie sind hier:
